AAAAAA

   
Results: 1-25 | 26-50 | 51-67
Results: 1-25/67
EPIRUBICIN AS A SINGLE-AGENT IN COMPARISON TO CMF IN ADJUVANT THERAPYOF STAGE-I AND STAGE-II BREAST-CANCER
Authors: COLOZZA M BISAGNI G MOSCONI AM GORI C BONI C BIAN AR SABBATINI R FRASSOLDATI A PASSALACQUA R RODINO C RONDINI E ALGERI R DISARRA S BACCHI M TONATO M COCCONI G
Citation: M. Colozza et al., EPIRUBICIN AS A SINGLE-AGENT IN COMPARISON TO CMF IN ADJUVANT THERAPYOF STAGE-I AND STAGE-II BREAST-CANCER, European journal of cancer, 34, 1998, pp. 86-86
INTERNATIONAL (PERUGIA) CONSENSUS ON ANTIEMETIC THERAPY - INTRODUCTION
Authors: TONATO M GRALLA RJ ROILA F
Citation: M. Tonato et al., INTERNATIONAL (PERUGIA) CONSENSUS ON ANTIEMETIC THERAPY - INTRODUCTION, Supportive care in cancer, 6(3), 1998, pp. 193-193
METHODOLOGY OF ANTIEMETIC TRIALS - RESPONSE ASSESSMENT, EVALUATION OFNEW AGENTS AND DEFINITION OF CHEMOTHERAPY EMETOGENICITY
Authors: HESKETH PJ GRALLA RJ DUBOIS A TONATO M
Citation: Pj. Hesketh et al., METHODOLOGY OF ANTIEMETIC TRIALS - RESPONSE ASSESSMENT, EVALUATION OFNEW AGENTS AND DEFINITION OF CHEMOTHERAPY EMETOGENICITY, Supportive care in cancer, 6(3), 1998, pp. 221-227
PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE
Authors: ROILA F DELFAVERO A GRALLA RJ TONATO M AAPRO MS ANDREWS PLR BALLATORI E DEMULDER PHM DICATO MA DUBOIS A FEYER PC GANDARA DR GRALLA RJ GRALLA RJ GROSHEN S GRUNBERG SM HERRSTEDT J HESKETH PJ JOSS RA KRIS MG MARTY MM MORROW GR NAYLOR RJ OLVER IN SMYTH JF SPITZER TR STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: DELFAVERO A ROILA F DEANGELIS V TONATO M BALLATORI E TUMOLO S MENEGHETTI L NEGRI D DELLAGASPERA S PRESOT C MURAN G LUCENTI A CICCARESE G PALLADINO MA PORROZZI S SABBATINI R DEPENNI R FEDERICO M SILINGARDI V SANSONI E MALTONI M MILANDRI C AMADORI D SABBIONI R NORTILLI R CETTO GL DOGLIOTTI L BUNIVA T GORZEGNO G LOPEZ M AMODIO A CONTI F FOGGI CM GIGLIO A DESIO L MANENTE P BERNARDO G STRADA MR VILLANI G GALLO L MERLINI L CAROTI C MAZZOTTA S FORCIGNANO R QUARTA G PACILIO C IODICE G ROSATI G MALACARNE P DONATI D MACCAFERRI R COMELLA G CASARETTI R CARRECA I RAUSA L FOSSER V SCHIAVON S GIOFFRE FM VENUTI A AMUNNI G VILLANUCCI A CONTU A PAZZOLA A PALMIOTTI G GAROFOLO G EPIFANI C GIORDANO M ANTIMI M MINELLI M DEVITA F DIGRAZIA M CRUCIANI G MONTANARI L MARCHEI P AMICI S ALESSANDRONI P CECCOLINI M CATTANEO MT ORLANDINI B AGOSTARA B MARZI M DIONISI MS DICOSTANZO F TROCCOLI L
Citation: A. Delfavero et al., TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Annals of oncology, 9(7), 1998, pp. 759-765
ADJUVANT CHEMOTHERAPY IN EUROPE
Authors: TONATO M
Citation: M. Tonato, ADJUVANT CHEMOTHERAPY IN EUROPE, Annals of oncology, 9, 1998, pp. 14-14
ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO)
Authors: DICOSTANZO F GASPERONI S CARLINI P TONATO M LABIANCA R BRAVI S FORNARINI G BISAGNI G SDROBOLINI A MANZIONE L
Citation: F. Dicostanzo et al., ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO), Annals of oncology, 9, 1998, pp. 252-252
ANTIEMETIC TREATMENT IN PATIENTS (PTS) SUBMITTED TO CONSECUTIVE DAYS OF 5-FLUOROURACIL (5-FU) + - FOLINIC ACID (FA)/
Authors: DEANGELIS V PALMIOTTI G EPIFANI C ANTIMI M CATALANO G CRUCIANI G AMICI S TONATO M ROILA F
Citation: V. Deangelis et al., ANTIEMETIC TREATMENT IN PATIENTS (PTS) SUBMITTED TO CONSECUTIVE DAYS OF 5-FLUOROURACIL (5-FU) + - FOLINIC ACID (FA)/, Annals of oncology, 9, 1998, pp. 680-680
VINORELBINE PLUS BEST SUPPORTIVE CARE (BSC) VS BSC IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) ELDERLY PATIENTS (PTS) -RESULTS OF A PHASE-III RANDOMIZED TRIAL
Authors: CLERICI M FRONTINI L IANNIELLO GP MAIORINO L PIANTEDOSI FV CIGOLARI S MANZIONE L FAILLA G ZUCCARINO L PEDICINI T VINANTE O CASTIGLIONE F BEARZ A TONATO M ROSSI A MONFARDINI S GALLO C PERRONE F GRIDELLI C
Citation: M. Clerici et al., VINORELBINE PLUS BEST SUPPORTIVE CARE (BSC) VS BSC IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) ELDERLY PATIENTS (PTS) -RESULTS OF A PHASE-III RANDOMIZED TRIAL, Annals of oncology, 9, 1998, pp. 64-64
DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942
DOUBLE-BLIND EVALUATION OF SHORT-TERM ANALGESIC EFFICACY OF ORALLY-ADMINISTERED DICLOFENAC, DICLOFENAC PLUS CODEINE, AND DICLOFENAC PLUS IMIPRAMINE IN CHRONIC CANCER PAIN
Authors: MINOTTI V DEANGELIS V RIGHETTI E CELANI MG ROSSETTI R LUPATELLI M TONATO M PISATI R MONZA G FUMI G DELFAVERO A
Citation: V. Minotti et al., DOUBLE-BLIND EVALUATION OF SHORT-TERM ANALGESIC EFFICACY OF ORALLY-ADMINISTERED DICLOFENAC, DICLOFENAC PLUS CODEINE, AND DICLOFENAC PLUS IMIPRAMINE IN CHRONIC CANCER PAIN, Pain, 74(2-3), 1998, pp. 133-137
A DOUBLE-BLIND-STUDY COMPARING 2 SINGLE-DOSE REGIMENS OF KETOROLAC WITH DICLOFENAC IN PAIN DUE TO CANCER
Authors: MINOTTI V BETTI M CICCARESE G FUMI G TONATO M DELFAVERO A
Citation: V. Minotti et al., A DOUBLE-BLIND-STUDY COMPARING 2 SINGLE-DOSE REGIMENS OF KETOROLAC WITH DICLOFENAC IN PAIN DUE TO CANCER, Pharmacotherapy, 18(3), 1998, pp. 504-508
CHEMOTHERAPY WITH CISPLATIN AND TENIPOSIDE FOR CEREBRAL METASTASES INNONSMALL CELL LUNG-CANCER
Authors: MINOTTI V CRINO L MEACCI ML CORGNA E DARWISH S PALLADINO MA BETTI M TONATO M
Citation: V. Minotti et al., CHEMOTHERAPY WITH CISPLATIN AND TENIPOSIDE FOR CEREBRAL METASTASES INNONSMALL CELL LUNG-CANCER, Lung cancer, 20(2), 1998, pp. 93-98
GEMCITABINE AS 2ND-LINE TREATMENT FOR RELAPSING OR REFRACTORY ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL
Authors: CRINO L MOSCONI AM SCAGLIOTTI GV SELVAGGI G RINALDI M DELLAGIULIA M GRIDELLI C CALANDRI C DEMARINIS F NOSEDA M TONATO M
Citation: L. Crino et al., GEMCITABINE AS 2ND-LINE TREATMENT FOR RELAPSING OR REFRACTORY ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL, Seminars in oncology, 25(4), 1998, pp. 23-26
THE ACTIVITY OF GEMCITABINE PLUS CISPLATIN IN RANDOMIZED TRIALS IN UNTREATED PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: ROSELL R TONATO M SANDLER A
Citation: R. Rosell et al., THE ACTIVITY OF GEMCITABINE PLUS CISPLATIN IN RANDOMIZED TRIALS IN UNTREATED PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 27-34
PROGNOSTIC IMPACT OF TISSUE CONCENTRATION OF UROKINASE (UPA), ITS RECEPTOR (UPAR), AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) ON THE SURVIVAL OF PATIENTS WITH BREAST-CANCER - A PROSPECTIVE-STUDY
Authors: COSTANTINI V CAZZATO AO PASQUALINI ME DEMONTE P VIENNA L MARIOTTI M DEVEGLIA R TONATO M NENCI GG
Citation: V. Costantini et al., PROGNOSTIC IMPACT OF TISSUE CONCENTRATION OF UROKINASE (UPA), ITS RECEPTOR (UPAR), AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) ON THE SURVIVAL OF PATIENTS WITH BREAST-CANCER - A PROSPECTIVE-STUDY, Thrombosis research, 91(3), 1998, pp. 273-273
5-HT3 RECEPTOR ANTAGONISTS - DIFFERENCES AND SIMILARITIES
Authors: ROILA F BALLATORI E TONATO M DELFAVERO A
Citation: F. Roila et al., 5-HT3 RECEPTOR ANTAGONISTS - DIFFERENCES AND SIMILARITIES, European journal of cancer, 33(9), 1997, pp. 1364-1370
DRUG UTILIZATION FOR PREVENTION OF CHEMOTHERAPY (CT)-INDUCED EMESIS
Authors: ROILA F BALLATORI E PALMIOTTI G EPIFANI C ANTIMI M CATALANO G CRUCIANI G AMICI S TONATO M
Citation: F. Roila et al., DRUG UTILIZATION FOR PREVENTION OF CHEMOTHERAPY (CT)-INDUCED EMESIS, European journal of cancer, 33, 1997, pp. 69-69
THE ROLE OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER
Authors: TONATO M
Citation: M. Tonato, THE ROLE OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1019-1019
INTENSIFIED CHEMOTHERAPY WITH CARBOPLATIN AND VP-16-CSF AFTER INDUCTION WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE (CEV) IN EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - A PHASE-II TRIAL(G)
Authors: CRINO L DEMARINIS F CORGNA E PORROZZI S CONTU E DARWISH S MINOTTI V TONATO M
Citation: L. Crino et al., INTENSIFIED CHEMOTHERAPY WITH CARBOPLATIN AND VP-16-CSF AFTER INDUCTION WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE (CEV) IN EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - A PHASE-II TRIAL(G), European journal of cancer, 33, 1997, pp. 1058-1058
GEMCITABINE IN ADVANCED PANCREATIC-CANCER - A PHASE-II TRIAL
Authors: CRINO L MOSCONI AM CALANDRI C CORGNA E DARWISH S TONATO M
Citation: L. Crino et al., GEMCITABINE IN ADVANCED PANCREATIC-CANCER - A PHASE-II TRIAL, European journal of cancer, 33, 1997, pp. 1266-1266
COMBINATION THERAPY WITH GEMCITABINE IN NONSMALL CELL LUNG-CANCER
Authors: MOSCONI AM CRINO L TONATO M
Citation: Am. Mosconi et al., COMBINATION THERAPY WITH GEMCITABINE IN NONSMALL CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 14-17
CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS
Authors: BALLATORI E ROILA F DEANGELIS V CICCARESE G PALLADINO MA TONATO M DELFAVERO A HERRSTEDT J DICATO M DUBOIS A HESKETH P KRIS M GRALLA RJ
Citation: E. Ballatori et al., CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS, Supportive care in cancer, 5(4), 1997, pp. 269-273
A BETTER THERAPEUTIC PROFILE FOR THE COMBINATION OF MITOMYCIN-C, IFOSFAMIDE AND CISPLATIN (MIC) IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A USEFUL DOSE-SCHEDULE MODIFICATION
Authors: CRINO L CORGNA E PORROZZI S PALLADINO MA DARWISH S MINOTTI V MOSCONI AM TONATO M
Citation: L. Crino et al., A BETTER THERAPEUTIC PROFILE FOR THE COMBINATION OF MITOMYCIN-C, IFOSFAMIDE AND CISPLATIN (MIC) IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A USEFUL DOSE-SCHEDULE MODIFICATION, Annals of oncology, 8(7), 1997, pp. 709-711
CISPLATIN-GEMCITABINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
Authors: CRINO L SCAGLIOTTI G MARANGOLO M FIGOLI F CLERICI M DEMARINIS F SALVATI F CRUCIANI G DOGLIOTTI L PUCCI F PACCAGNELLA A ADAMO V ALTAVILLA G INCORONATO P TRIPPETTI M MOSCONI AM SANTUCCI A SORBOLINI S OLIVA C TONATO M
Citation: L. Crino et al., CISPLATIN-GEMCITABINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 15(1), 1997, pp. 297-303
Risultati: 1-25 | 26-50 | 51-67